RN-18

CAS No. 431980-38-0

RN-18 ( Vif inhibitor RN-18 )

Catalog No. M14465 CAS No. 431980-38-0

RN-18 is a small molecule that antagonizes HIV-1 Vif function and inhibits HIV-1 replication only in the presence of A3G.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 80 Get Quote
10MG 135 Get Quote
25MG 299 Get Quote
50MG 507 Get Quote
100MG 714 Get Quote
500MG 1503 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RN-18
  • Note
    Research use only, not for human use.
  • Brief Description
    RN-18 is a small molecule that antagonizes HIV-1 Vif function and inhibits HIV-1 replication only in the presence of A3G.
  • Description
    RN-18 is a small molecule that antagonizes HIV-1 Vif function and inhibits HIV-1 replication only in the presence of A3G; increases cellular A3G levels in a Vif-dependent manner and increases A3G incorporation into virions without inhibiting general proteasome-mediated protein degradation; enhances Vif degradation, reduces viral infectivity by increasing A3G incorporation into virions and enhances cytidine deamination of the viral genome.
  • Synonyms
    Vif inhibitor RN-18
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    431980-38-0
  • Formula Weight
    380.42
  • Molecular Formula
    C20H16N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 100 mg/mL 262.87 mM; H2O : < 0.1 mg/mL
  • SMILES
    COC1=CC=CC=C1NC(=O)C2=CC=CC=C2SC3=CC=C(C=C3)[N+](=O)[O-]
  • Chemical Name
    N-(2-Methoxyphenyl)-2-[(4-nitrophenyl)thio]benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nathans R, et al. Nat Biotechnol. 2008 Oct;26(10):1187-92.
2. Mohammed I, et al. J Med Chem. 2016 Aug 25;59(16):7677-82.
molnova catalog
related products
  • Efavirenz

    A highly potent nonnucleoside inhibitor (NNRTI) of HIV-1 reverse transcriptase with Ki of 2.93 nM for WT HIV-1 RT.

  • Rilpivirine

    A highly potent nonnucleoside inhibitor (NNRTI) of HIV-1 reverse trK7912:M7912anscriptase with IC50 of 0.4 nM for WT HIV-1 in cell-based assay.

  • Terameprocol

    Terameprocol is a synthetic tetra-methylated derivative of nordihydroguaiaretic acid (NDGA) and transcriptional inhibitor with potential antiviral, antiangiogenic, and antineoplastic activities. Terameprocol showed the strongest anti-HIV activity.